Biotech RadarJobs updated

COMPANY

CathWorks

cath.works ↗

FDA-cleared device company

Keywords: digital health Percutaneous Coronary Intervention Multi Vessel Coronary Artery Disease Coronary Artery Disease CAD - Coronary Artery Disease FFRangio

Profile checked Oct 10, 2026

4Trials (company is sponsor)

Timeline

  1. Trial start Not phased (device or behavioral study): Advancing Cath Lab Results With FFRangio Coronary Physiology Assessment source ↗
  2. Trial start —: Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease source ↗
  3. Trial start —: FFRangio Accuracy vs. Standard FFR source ↗
  4. Trial start —: Angiogram Based Fractional Flow Reserve FFRangio - A Validation Study source ↗

Clinical trials (lead sponsor) 4

RecordTitlePhaseStatusStartPrimary completion
NCT05893498Advancing Cath Lab Results With FFRangio Coronary Physiology AssessmentNot phased (device or behavioral study)Active, not recruitingJun 21, 20232026-05 (estimated)
NCT03455244Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel DiseaseNot listedCompletedNov 14, 2017May 2, 2018 (actual)
NCT03226262FFRangio Accuracy vs. Standard FFRNot listedCompletedSep 27, 2017Jun 8, 2018 (actual)
NCT03005028Angiogram Based Fractional Flow Reserve FFRangio - A Validation StudyNot listedCompleted2015-01Mar 15, 2016 (actual)
Feedback